PDF herunterladen
Nervenheilkunde 2010; 29(03): 117-123
DOI: 10.1055/s-0038-1628725
CME-Fortbildung
Schattauer GmbH

Elektrokrampftherapie und neue Hirnstimulationsmethoden

Electroconvulsive therapy and new brain stimulation methods
S. Kayser
1   Universitätsklinikum Bonn, Klinik für Psychiatrie und Psychotherapie, Bonn
,
H. Walter
1   Universitätsklinikum Bonn, Klinik für Psychiatrie und Psychotherapie, Bonn
2   Universitätsklinikum Bonn, Klinik für Psychiatrie und Psychotherapie, Abteilung Medizinische Psychologie, Bonn
,
T. Schläpfer
1   Universitätsklinikum Bonn, Klinik für Psychiatrie und Psychotherapie, Bonn
3   Departments of Mental Health and Psychiatric Neuroimaging, Johns Hopkins University, Baltimore, MD, USA
› Institutsangaben
Weitere Informationen

Publikationsverlauf

Eingegangen am: 02. November 2009

angenommen am: 03. November 2009

Publikationsdatum:
24. Januar 2018 (online)

    Lizenzen und Reprints

Zusammenfassung

Die Elektrokrampftherapie (EKT) wird seit über 70 Jahren angewandt und ist zurzeit wissenschaftlich das potenteste antidepressive Behandlungsverfahren. Insbesondere in Deutschland ist die EKT noch immer ein massiv stigmatisiertes Verfahren. Der Wirkmechanismus ist nicht abschließend geklärt. Trotz ständiger technischer Verbesserungen hat die EKT zwei grundlegende Nachteile: eine hohe Rückfallquote und zum Teil ausgeprägte akute kognitive Nebenwirkungen. Es besteht in der Psychiatrie ein dringender Bedarf an neueren Behandlungsoptionen für schwerste, therapieresistente psychiatrische Erkrankungen. Derzeit werden als potenzielle neue Behandlungsmethoden von psychischen Störungen hauptsächlich vier physikalische Hirnstimulationsmethoden untersucht: die transkranielle Magnetstimulation (TMS), die Magnetkrampftherapie (MKT), die Vagusnervstimulation (VNS) und die tiefe Hirnstimulation (THS). Diese werden nur in Einzelfällen außerhalb von wissenschaftlichen Studien angewendet; ihre klinische Bedeutung und die Wirkmechanismen müssen weiter untersucht werden. Keines der neuen Stimulationsmethoden ist in psychiatrischer Indikation die Therapie der ersten Wahl.

Summary

The electroconvulsive therapy (ECT) has been used for more than 70 years and it is currently the most potent antidepressant treatment with scientifically evidence. Still the ECT is a massive stigmatized treatment, especially in Germany. The mode of action of the ECT is not fully understood. Despite the technical improvements, there are two major disadvantages of the ECT: a high rate of relapse and the acute cognitive side effects, sometimes severe. In psychiatry, there is an urgent need of new treatment methods for severely treatment-resistant diseases. Currently, there are four physical methods of brain stimulation being researched: transcranial magnetic stimulation (TMS), magnetic seizure therapy (MST), vagus nerve stimulation (VNS) and deep brain stimulation (DBS). Beyond scientific studies, these are only applied in single cases at present. Their clinical importance and their mode of action have to be subject of further research. None of these new stimulation methods is a measure of first choice treatment presently in psychiatric disorders.

Schlüsselwörter

Elektrokrampftherapie - repetitive Transkranielle Magnetstimulation - Vagusnervstimulation - Magnetkrampftherapie - tiefe Hirnstimulation

Keywords

Electroconvulsive therapy - repetitive transcranial magnetic stimulation - vagus nerve stimulation - magnetic seizure therapy - deep brain stimulation
 

  • Literatur

  • 1 Cerletti U, Bini EL. Un nuevo metodo di shockterapie “L` Elettroshock”. Bollettino Accademia Medica Roma 1938; 64: 136-138.
    Google Scholar
  • 2 Baghai T. et al. (eds.). Elektrokonvulsionstherapie: Klinische und wissenschaftliche Aspekte. Wien: Springer 2004
    Google Scholar
  • 3 Tölle R. Nicht die Elektrokrampftherapie, sondern ihre Gegner stehen in der Kritik. Nervenarzt 2008; 79: 1310-1312.
    CrossrefPubMedGoogle Scholar
  • 4 Fink M, Taylor MA. Electroconvulsive therapy: evidence and challenges. JAMA 2007; 298: 330-332.
    CrossrefPubMedGoogle Scholar
  • 5 Lisanby SH. Electroconvulsive therapy for depression. N Engl J Med 2008; 357: 1939-1945.
    Google Scholar
  • 6 Petrides G. et al. ECT remission rates in psychotic versus nonpsychotic depressed patients: a report from CORE. J ECT 2001; 17: 244-253.
    CrossrefPubMedGoogle Scholar
  • 7 Sackeim HA. et al. Continuation pharmacotherapy in the prevention of relapse following electroconvulsive therapy: a randomized controlled trial. JAMA 2001; 285: 1299-1307.
    CrossrefPubMedGoogle Scholar
  • 8 Weiner RD. (ed.). The practice of electroconvulsive therapy: Recommendations for treatment, training, and privileging: A task force report of the American Psychiatric Association. Washington, DC: American Psychiatric Association; 2001
    Google Scholar
  • 9 Spellman T. et al. Differential effects of high-dose magnetic seizure therapy and electroconvulsive shock on cognitive function. Biological Psychiatry 2008; 63 (02) 1163-1170.
    CrossrefPubMedGoogle Scholar
  • 10 UK ECT Review Group. Efficacy and safety of electroconvulsive therapy in depressive disorders: a systematic review and meta-analysis. Lancet 2003; 361: 799-808.
    CrossrefPubMedGoogle Scholar
  • 11 Folkerts H. et al. Bekanntmachungen: Stellungnahme zur Elektrokrampftherapie (EKT) als psychiatrische Behandlungsmaßnahme. Deutsches Ärzteblat 2003; 100: A504.
    Google Scholar
  • 12 Bschor T, Adli M. Therapie depressiver Erkrankungen. Deutsches Ärzteblatt 2008; 105: 782-792.
    Google Scholar
  • 13 Henn FA, Vollmayr B, Sartorius A. Mechanisms of depression: the role of neurogenesis. Drug Discovery Today: Disease Mechanisms 2004; 01: 407-411.
    Google Scholar
  • 14 Bourgon LN, Kellner CH. Relapse of depression after ECT: a review. J ECT 2000; 16: 19-31.
    CrossrefPubMedGoogle Scholar
  • 15 Eschweiler GW, Rapp AM. Aktuelles zur Elektrokrampftherapie bei schweren depressiven Störungen. Nervenheilkunde 2008; 27: 1049-1054.
    Artikel in Thieme ConnectGoogle Scholar
  • 16 Sartorius A, Henn FA. Erhaltungselektrokrampftherapie bei depressiven Störungen. Nervenarzt 2005; 76: 1363-1369.
    CrossrefPubMedGoogle Scholar
  • 17 McCall WV. et al. Titrated moderately suprathreshold vs fixed highdose right unilateral electroconvulsive therapy: acute antidepressant and cognitive effects. Arch Gen Psychiatry 2000; 57: 438-444.
    CrossrefPubMedGoogle Scholar
  • 18 Sackeim HA. et al. A prospective, randomized, doubleblind comparison of bilateral and right unilateral electroconvulsive therapy at different stimulus intensities. Arch Gen Psychiatry 2000; 57: 425-434.
    CrossrefPubMedGoogle Scholar
  • 19 Squire LR, Slater PC, Miller PL. Retrograde amnesia and bilateral electroconvulsive therapy. Long-term follow-up. Arch Gen Psychiatry 1981; 38: 89-95.
    CrossrefPubMedGoogle Scholar
  • 20 Sackeim HA. et al. The cognitive effects of electroconvulsive therapy in community settings. Neuropsychopharmacology 2007; 32: 244-254.
    CrossrefPubMedGoogle Scholar
  • 21 Devanand DP. et al. Does ECT alter brain structure?. Am J Psychiatry 1994; 151 (07) 957-70.
    CrossrefPubMedGoogle Scholar
  • 22 Angst J. et al. ECT-Induced and Drug-Induced Hypomania. Convuls Ther 1992; 08 (03) 179-85.
    Google Scholar
  • 23 Devanand D. et al. The development of mania and organic euphoria during ECT. J Clin Psychiatry 1988; 49 (02) 69-71.
    PubMedGoogle Scholar
  • 24 Ridding MC, Rothwell JC. Is there a future for therapeutic use of transcranial magnetic stimulation?. Nat Rev Neurosci 2007; 08 (07) 559-67.
    CrossrefPubMedGoogle Scholar
  • 25 Schlaepfer TE, Kosel M, Nemeroff CB. Efficacy of repetitive transcranial magnetic stimulation (rTMS) in the treatment of affective disorders. Neuropsychopharmacology 2003; 28 (02) 201-5.
    CrossrefPubMedGoogle Scholar
  • 26 Schulze-Rauschenbach SC. et al. Distinctive neurocognitive effects of repetitive transcranial magnetic stimulation and electroconvulsive therapy in major depression. Br J Psychiatry 2005; 186: 410-6.
    CrossrefPubMedGoogle Scholar
  • 27 Herrmann LL, Ebmeier KP. Factors modifying the efficacy of transcranial magnetic stimulation in the treatment of depression: a review. J Clin Psychiatry 2006; 67 (12) 1870-6.
    CrossrefPubMedGoogle Scholar
  • 28 Martin JL. et al. Transcranial magnetic stimulation for treating depression. Cochrane Database Syst Rev 2002; (02) CD003493.
    PubMedGoogle Scholar
  • 29 O’Reardon JP. et al. Efficacy and safety of transcranial magnetic stimulation in the acute treatment of major depression: a multisite randomized controlled trial. Biol Psychiatry 2007; 62 (11) 1208-16.
    CrossrefPubMedGoogle Scholar
  • 30 Wassermann EM. Risk and safety of repetitive transcranial magnetic stimulation: report and suggested guidelines from the International Workshop on the Safety of Repetitive Transcranial Magnetic Stimulation, June, 1996. Electroencephalogr Clin Neurophysiol 1998; 108 (01) 1-16.
    CrossrefPubMedGoogle Scholar
  • 31 Lisanby SH. et al. Magnetic seizure therapy of major depression. Arch Gen Psychiatry 2001; 58 (03) 303-5.
    CrossrefPubMedGoogle Scholar
  • 32 Kayser S. et al. Effects of Magnetic Seizure Therapy and Electroconvulsive Therapy in Treatment-Resistant Depression. Eingereicht.
    Google Scholar
  • 33 Kosel M. et al. Magnetic seizure therapy improves mood in refractory major depression. Neuropsychopharmacology 2003; 28 (11) 2045-8.
    CrossrefPubMedGoogle Scholar
  • 34 Lisanby SH. et al. Safety and feasibility of magnetic seizure therapy (MST) in major depression: randomized within-subject comparison with electroconvulsive therapy. Neuropsychopharmacology 2008; 28 (10) 1852-65.
    Google Scholar
  • 35 Moscrip TD. et al. Randomized controlled trial of the cognitive side-effects of magnetic seizure therapy (MST) and electroconvulsive shock (ECS). Int J Neuropsychopharmacol 2006; 09 (01) 1-11.
    CrossrefGoogle Scholar
  • 36 Kayser S. et al. Magnetic seizure therapy of treatment-resistant depression in a patient with bipolar disorder. J ECT 2009; 25 (02) 137-40.
    CrossrefPubMedGoogle Scholar
  • 37 Kirov G. et al. Quick recovery of orientation after magnetic seizure therapy for major depressive disorder. Br J Psychiatry 2008; 193 (02) 152-5.
    CrossrefPubMedGoogle Scholar
  • 38 White PF. et al. Anesthetic considerations for magnetic seizure therapy: a novel therapy for severe depression. Anesth Analg 2006; 103 (01) 76-80.
    CrossrefPubMedGoogle Scholar
  • 39 George MS. et al. Vagus nerve stimulation: a new tool for brain research and therapy. Biol Psychiatry 2000; 47 (04) 287-95.
    CrossrefPubMedGoogle Scholar
  • 40 Kosel M, Schlaepfer TE. Mechanisms and state of the art of vagus nerve stimulation. J ECT 2002; 18 (04) 189-92.
    CrossrefPubMedGoogle Scholar
  • 41 Nemeroff CB. et al. VNS therapy in treatment-resistant depression: clinical evidence and putative neurobiological mechanisms. Neuropsychopharmacology 2006; 31 (07) 1345-55.
    CrossrefPubMedGoogle Scholar
  • 42 Nahas Z. et al. Two-year outcome of vagus nerve stimulation (VNS) for treatment of major depressive episodes. J Clin Psychiatry 2005; 66 (09) 1097-104.
    CrossrefPubMedGoogle Scholar
  • 43 Schlaepfer TE. et al. Vagus nerve stimulation for depression: efficacy and safety in a European study. Psychol Med 2008; 38 (05) 651-61.
    CrossrefPubMedGoogle Scholar
  • 44 Frick C. et al. Incident mania during therapy with vagus nerve stimulation. J ECT 2005; 21 (03) 197.
    CrossrefPubMedGoogle Scholar
  • 45 Deuschl G. et al. A randomized trial of deep-brain stimulation for Parkinson’s disease. N Engl J Med 2006; 355 (09) 896-908.
    CrossrefPubMedGoogle Scholar
  • 46 Synofzik M, Schlaepfer TE. Stimulating personality: ethical criteria for deep brain stimulation in psychiatric patients and for enhancement purposes. Biotechnol J 2008; 03 (12) 1511-20.
    CrossrefPubMedGoogle Scholar
  • 47 Schlaepfer TE, Lieb K. Deep brain stimulation for treatment of refractory depression. Lancet 2005; 366 9495 1420-1422.
    CrossrefPubMedGoogle Scholar
  • 48 Malone DA. et al. Deep brain stimulation of the ventral capsule/ventral striatum for treatment-resistant depression. Biol Psychiatry 2009; 65 (04) 267-75.
    CrossrefPubMedGoogle Scholar
  • 49 Lozano AM. et al. Subcallosal cingulate gyrus deep brain stimulation for treatment-resistant depression. Biol Psychiatry 2008; 64 (06) 461-7.
    CrossrefPubMedGoogle Scholar
  • 50 Mayberg HS. et al. Deep brain stimulation for treatment-resistant depression. Neuron 2005; 45: 651-660.
    CrossrefPubMedGoogle Scholar
  • 51 McNeely HE. et al. Neuropsychological impact of Cg25 deep brain stimulation for treatment-resistant depression: preliminary results over 12 months. J Nerv Ment Dis 2008; 196 (05) 405-10.
    CrossrefPubMedGoogle Scholar
  • 52 Bewernick B. et al. Nucleus accumbens deep brain stimulation decreases ratings of depression and anxiety in treatment-resistant depression. Biological Psychiatry 2009; Nov. 13.
    Google Scholar
  • 53 Cohen MX. et al. Deep brain stimulation to reward circuitry alleviates anhedonia in refractory major depression. Neuropsychopharmacology 2008; 33 (02) 368-77.
    CrossrefPubMedGoogle Scholar
  • 54 Schlaepfer TE, Bewernick BH. Deep brain stimulation for psychiatric disorders – state of the art. Wien: Springer 2008
    PubMedGoogle Scholar
  • 55 Dougherty DD, Thase ME. Feasibility Study of an Implantable Cortical Stimulation System for Patients with Major Depressive Disorder. Biol Psychiatry 2008; 63 (67) 930.
    Google Scholar
  • 56 Boros K. et al. Premotor transcranial direct current stimulation (tDCS) affects primary motor excitability in humans. Eur J Neurosci 2008; 27 (05) 1292-300.
    CrossrefPubMedGoogle Scholar
  • 57 Boggio PS. et al. Temporal cortex direct current stimulation enhances performance on a visual recognition memory task in Alzheimer disease. J Neurol Neurosurg Psychiatry 2009; 80 (04) 444-7.
    PubMedGoogle Scholar
  • 58 Klawansky S. et al. Meta-analysis of randomized controlled trials of cranial electrostimulation. Efficacy in treating selected psychological and physiological conditions. J Nerv Ment Dis 1995; 183 (07) 478-84.
    CrossrefPubMedGoogle Scholar